New immunotherapy combo shrinks lung cancer
Sciworthy,
The most common form of lung cancer, called non-small cell lung cancer, affects more than 200,000 people in the US each year.
The most common form of lung cancer, called non-small cell lung cancer, affects more than 200,000 people in the US each year.
By Melissa Bedard, MRC Human Immunology Unit, MRC Weatherall Institute of Molecular…
Welcome to the June High Five! On a monthly basis, the High Five post highlights the papers that have received the most…
Researchers designed a novel approach to immunotherapy that led to the complete regression of breast cancer in one patient for…